Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-23

Clinical Trial Update: False Lumen Treatment for Prevention of Aortic Growth Using Shape Memory Polymer - First-in-Human Study [NA]

View source ↗

Summary

A first-in-human trial update evaluating a shape memory polymer to seal the false lumen and prevent aortic growth in patients with aortic dissection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Shape Memory Polymer (false lumen treatment) (shape memory polymer)

Snippet

Sponsor: Shape Memory Medical, Inc. | Conditions: Aortic Dissection | NA | Status: RECRUITING